Status:
COMPLETED
Tracking Treatment Pathways in Adult Patients With Hyperkalemia.
Lead Sponsor:
AstraZeneca
Conditions:
Hyperkalemia
Eligibility:
All Genders
18-130 years
Brief Summary
This study aims to increase the understanding of Hyperkalemia (HK) management, treatment patterns, and the treatment decision-making process for the management of patients with HK over a period of up ...
Detailed Description
This study is a multinational, observational, prospective, longitudinal, cohort study that will include primary and secondary data collection. Secondary data, collected as per routine clinical practic...
Eligibility Criteria
Inclusion
- Patients meeting all the following inclusion criteria will be eligible for inclusion into the study:
- Age ≥18 years on the date of signing informed consent
- HK with serum potassium (K+) level(s) greater than 5.0 mmol/L, collected during Standard of Care, within 21 days prior to the date of enrollment\*
- Provision of signed and dated informed consent
- (\*enrollment in study is defined as the date of Informed consent and confirmation of study eligibility, whichever occurs later).
- Patients will be excluded from the study if they meet any of the following criteria:
- Concurrent participation in any trial that includes the use of K+ binders as an investigational medicinal product (IMP)
- Patients with pseudohyperkalemia
- A life expectancy of less than six months, based on physician judgement
- Acute causes of HK such as infections and/or trauma to be determined by the principal investigator
- Scheduled renal transplant
- Involvement in the planning and/or conduct of the study
Exclusion
Key Trial Info
Start Date :
July 14 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 19 2024
Estimated Enrollment :
1331 Patients enrolled
Trial Details
Trial ID
NCT05408039
Start Date
July 14 2022
End Date
December 19 2024
Last Update
July 15 2025
Active Locations (74)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Huntsville, Alabama, United States, 35805
2
Research Site
La Jolla, California, United States, 92037
3
Research Site
Rancho Cucamonga, California, United States, 91730
4
Research Site
New Haven, Connecticut, United States, 06511